(1) Annex 4 is to be read as follows.
(2) Section 1 is to be read as if—
(a) in the heading, “Harmonised” were omitted;
(b) in the paragraph, “harmonised” were omitted”;
(c) after the paragraph there were inserted—
In this Annex, “approvals register” has the meaning given in Article 3(31B) of Regulation 1107/2009 .
(3) Section 2 is to be read as if—
(a) “Harmonised” in each place it occurs (including in the headings) were omitted;
(b) in paragraph 1, in the first sentence, for the words from “provided to” to the end there were substituted—
in relation to Northern Ireland, collected in accordance with Annex 4 to Directive 2009/128/EC , otherwise, collected in accordance with Article 67(3) of that Regulation.
(c) for paragraph 2(b) to (e) there were substituted—
(b) the active substances in Group 1 (categories A and B)—
(i) in relation to Northern Ireland, are those listed in Part D of the Annex to Commission Implementing Regulation (EU) No 540/2011;
(ii) otherwise, are those listed as low-risk active substances in the approvals register;
(c) the active substances in Group 2 (categories C and D)—
(i) in relation to Northern Ireland, are those listed in Parts A and B of the Annex to Commission Implementing Regulation (EU) No 540/2011;
(ii) otherwise, are those listed in the approvals register as active substances which are not basic substances, low-risk active substances or candidates for substitution;
(d) the active substances in Group 3 (categories E and F)—
(i) in relation to Northern Ireland, are those listed in Part E of the Annex to Commission Implementing Regulation (EU) No 540/2011;
(ii) otherwise, are those listed as candidates for substitution in the approvals register;
(e) the active substances in Group 4 (category G) are those not approved under Regulation (EC) No 1107/2009 , and therefore not listed—
(i) in relation to Northern Ireland, in the Annex to Commission Implementing Regulation (EU) No 540/2011;
(ii) otherwise, in the approvals register;
(d) in Table 1, in Row (i)—
(i) in the second column—
(aa) after “listed” there were inserted “, in relation to Northern Ireland,”;
(bb) at the end there were inserted “, or, otherwise, in the approvals register”;
(ii) for the entry in the third column there were substituted—
Active substances approved or deemed to be approved under Regulation (EC) No 1107/2009 which—
(a) in relation to Northern Ireland—
(i) do not fall in other categories, and
(ii) are listed in Parts A and B of the Annex to Implementing Regulation (EU) No 540/2011;
(b) otherwise, are not basic substances, low-risk active substances or candidates for substitution and are listed in the approvals register
(iii) in the fourth and fifth columns—
(aa) after “listed” there were inserted “, in relation to Northern Ireland,”;
(bb) at the end there were inserted “, or, otherwise, in the approvals register”;
(e) in paragraph 7—
(i) for “Member States and the Commission” there were substituted “appropriate United Kingdom competent authority”;
(ii) for “15(4)” there were substituted “15(3)”.
(4) Section 3 is to be read as if—
(a) “Harmonised” in each place it occurs (including in the headings) were omitted;
(b) in paragraph 1, in the first sentence, after “Regulation (EC) No 1107/2009 ” there were inserted “and, in relation to Northern Ireland only,”;
(c) for paragraph 2(b) to (e) there were substituted—
(b) the active substances in Group 1 (categories A and B)—
(i) in relation to Northern Ireland, are those listed in Part D of the Annex to Commission Implementing Regulation (EU) No 540/2011;
(ii) otherwise, are those listed as low-risk active substances in the approvals register;
(c) the active substances in Group 2 (categories C and D)—
(i) in relation to Northern Ireland, are those listed in Parts A and B of the Annex to Commission Implementing Regulation (EU) No 540/2011;
(ii) otherwise, are those listed in the approvals register as active substances which are not basic substances, low-risk active substances or candidates for substitution;
(d) the active substances in Group 3 (categories E and F)—
(i) in relation to Northern Ireland, are those listed in Part E of the Annex to Commission Implementing Regulation (EU) No 540/2011;
(ii) otherwise, are those listed as candidates for substitution in the approvals register;
(e) the active substances in Group 4 (category G) are those not approved under Regulation (EC) No 1107/2009 , and therefore not listed—
(i) in relation to Northern Ireland, in the Annex to Commission Implementing Regulation (EU) No 540/2011;
(ii) otherwise, in the approvals register;
(d) in Table 2, in row (i)—
(i) in the second column—
(aa) after “listed” there were inserted “, in relation to Northern Ireland,”;
(bb) at the end there were inserted “, or, otherwise, in the approvals register”;
(ii) for the entry in the third column there were substituted—
Active substances approved or deemed to be approved under Regulation (EC) No 1107/2009 which—
(a) in relation to Northern Ireland—
(i) do not fall in other categories, and
(ii) are listed in Parts A and B of the Annex to Implementing Regulation (EU) No 540/2011;
(b) otherwise, are not basic substances, low-risk active substances or candidates for substitution and are listed in the approvals register
(iii) in the fourth and fifth columns—
(aa) after “listed” there were inserted “, in relation to Northern Ireland,”;
(bb) at the end there were inserted “, or, otherwise, in the approvals register”;
(e) in paragraph 6—
(i) for “Member States and the Commission” there were substituted “appropriate United Kingdom competent authority”;
(ii) for “15(4)” there were substituted “15(3)”.